← FDA Drug Approvals (Drugs@FDA)
ICOSAPENT ETHYL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2021-06-30
Drug application
- FDA Application #
ANDA209437- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ICOSAPENT ETHYL
- Generic name
- ICOSAPENT ETHYL
- Active ingredients
- ICOSAPENT ETHYL
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APOTEX
- Manufacturer
- Apotex Corp
- First approval
- 2021-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown